2023 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2023)-3¿ù 30ÀÏ(1ÀÏÂ÷) : 2023-03-30±³À°ÀÏÀÚ : 2023-03-30±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ ±³À°ÁÖÁ¦ : 2023 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2023)-3¿ù 30ÀÏ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í ÀüÀÓÀÇ/¿¬±¸¿ø/°£È£»ç/ÀüÀÓÀÇ 100000¿ø, ºñȸ¿ø 300000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 09:00~09:25 How to diagnosis and treat neutropenia in childhood Kelly Walkovich(University of Michigan, ,USA)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 09:25~09:50 Updates in the treatment of pediatric relapsed/refractory acute myeloid leukemia Keon Hee Yoo(Sungkyunkwan University School of Medicine)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 09:50~10:15 CAR T cells and Acute lymphoblastic leukemia: Current state, challenges and future approaches Micheal Verneris(Children¡¯s Hospital Colorado, USA)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 10:30~11:15 Regulation of iron metabolism Martina U. Muckenthaler(University of Heidelberg, Germany)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 11:15~12:00 What can Nano do for Medicine? Taeghwan Hyeon(Seoul National University, Korea)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 12:15~13:05 ASCIMINIB, new paradigm treatment option in CML for patients who were previously treated with 2 or more TKIs Andreas Hocchaus(Jena University Hospital, Germany)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 13:20~14:50 Prognostic value of genomic clusters using machine learning in older adults with AML Tong Yoon Kim(The Catholic University of Korea, Korea)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 15:05~15:30 Aplastic anemia: Current management considerations Emma M. Groarke(National Institutes of Health, USA)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 15:30~15:50 Clinical and molecular factors of clonal evolution in aplastic anemia Jaroslaw P. Maciejewski |%$|(Cleveland Clinic, USA)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 15:50~16:30 Non-transplant therapy for pediatric aplastic anemia Jae Wook Lee(The Catholic University of Korea)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 16:35~16:50 Artificial intelligence in hematology: basic concepts Roni Shouval(Memorial Sloan Kettering Cancer Center, USA)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 16:50~17:25 BGB-11417 the new Bcl-2 inhibitor, the story so far David Simpson(BeiGene, Ltd. New Zealand)
±³À°½Ã°£ 03-30 ºñ½ºÅ¸È¦ 17:25~17:50 Bispecific antibody : ABL Bio Jonghwa Won(ABL Bio Inc., Korea)